Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-004359-34Phase 2Active
Phase 2 trial of sirolimus in Disorders of Immunity, sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2020; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-004359-34.